Cargando…

Tramiprosate, a drug of potential interest for the treatment of Alzheimer's disease, promotes an abnormal aggregation of tau

Alzheimer's disease (AD) is characterized by the presence of two histopathological hallmarks; the senile plaques, or extracellular deposits mainly composed of amyloid-β peptide (Aβ), and the neurofibrillary tangles, or intraneuronal inclusions composed of hyperphosphorylated tau protein. Since...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santa-Maria, Ismael, Hernández, Félix, Del Rio, Joaquín, Moreno, Francisco J, Avila, Jesús
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central\|1 2007
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2048960/ https://www.ncbi.nlm.nih.gov/pubmed/17822548 http://dx.doi.org/10.1186/1750-1326-2-17

Ejemplares similares

A Review on Tramiprosate (Homotaurine) in Alzheimer's Disease and Other Neurocognitive Disorders
por: Manzano, Sagrario, et al.
Publicado: (2020)

Tau Phosphorylation, Aggregation, and Cell Toxicity
por: Avila, J., et al.
Publicado: (2006)

Elucidating the Aβ42 Anti-Aggregation Mechanism of Action of Tramiprosate in Alzheimer’s Disease: Integrating Molecular Analytical Methods, Pharmacokinetic and Clinical Data
por: Kocis, Petr, et al.
Publicado: (2017)

Clinical Pharmacokinetics and Safety of ALZ-801, a Novel Prodrug of Tramiprosate in Development for the Treatment of Alzheimer’s Disease
por: Hey, John A., et al.
Publicado: (2017)

Tramiprosate in mild-to-moderate Alzheimer’s disease – a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study)
por: Aisen, Paul S., et al.
Publicado: (2011)

A new non-aggregative splicing isoform of human Tau is decreased in Alzheimer’s disease
por: García-Escudero, Vega, et al.
Publicado: (2021)

Specific Peptide from the Novel W-Tau Isoform Inhibits Tau and Amyloid β Peptide Aggregation In Vitro
por: Cuadros, Raquel, et al.
Publicado: (2022)

Toxic tau: structural origins of tau aggregation in Alzheimer's disease
por: Mamun, Abdullah Al, et al.
Publicado: (2020)

Thermodynamics of the Interaction between Alzheimer's Disease Related Tau Protein and DNA
por: Camero, Sergio, et al.
Publicado: (2014)

Discovery and Identification of an Endogenous Metabolite of Tramiprosate and Its Prodrug ALZ-801 that Inhibits Beta Amyloid Oligomer Formation in the Human Brain
por: Hey, John A., et al.
Publicado: (2018)

Phospho-Tau Changes in the Human CA1 During Alzheimer’s Disease Progression
por: Regalado-Reyes, Mamen, et al.
Publicado: (2019)

Specific binding of Hsp27 and phosphorylated Tau mitigates abnormal Tau aggregation-induced pathology
por: Zhang, Shengnan, et al.
Publicado: (2022)

Microglia in Alzheimer’s Disease in the Context of Tau Pathology
por: Perea, Juan Ramón, et al.
Publicado: (2020)

Kinetics of tau aggregation reveals patient-specific tau characteristics among Alzheimer’s cases
por: Kamath, Tarun V, et al.
Publicado: (2021)

Propagation of Tau via Extracellular Vesicles
por: Pérez, Mar, et al.
Publicado: (2019)

Relationship between cortical iron and tau aggregation in Alzheimer’s disease
por: Spotorno, Nicola, et al.
Publicado: (2020)

Photoexcited Toluidine Blue Inhibits Tau Aggregation in Alzheimer’s Disease
por: Dubey, Tushar, et al.
Publicado: (2019)

Tau Aggregation Inhibiting Peptides as Potential Therapeutics for Alzheimer Disease
por: Aillaud, Isabelle, et al.
Publicado: (2022)

Marked Mild Cognitive Deficits in Humanized Mouse Model of Alzheimer’s-Type Tau Pathology
por: Cho, Joshua D., et al.
Publicado: (2021)

The Involvement of Cholinergic Neurons in the Spreading of Tau Pathology
por: Simón, Diana, et al.
Publicado: (2013)

New Features about Tau Function and Dysfunction
por: Medina, Miguel, et al.
Publicado: (2016)

In vitro generation of tau aggregates conformationally distinct from parent tau seeds of Alzheimer’s brain
por: Nam, Won-Hee, et al.
Publicado: (2018)

GSK-3 and Tau: A Key Duet in Alzheimer’s Disease
por: Sayas, Carmen Laura, et al.
Publicado: (2021)

Microfluidic Protein Imaging Platform: Study of Tau Protein Aggregation and Alzheimer’s Drug Response
por: Jain, Shubha, et al.
Publicado: (2020)

Neuronal Models for Studying Tau Pathology
por: Koechling, Thorsten, et al.
Publicado: (2010)

A Simple Model to Study Tau Pathology
por: Houck, Alexander L., et al.
Publicado: (2016)

Tau Spreading Mechanisms; Implications for Dysfunctional Tauopathies
por: Fuster-Matanzo, Almudena, et al.
Publicado: (2018)

Suppressing Tau Aggregation and Toxicity by an Anti-Aggregant Tau Fragment
por: Pir, Ghulam Jeelani, et al.
Publicado: (2018)

Seeding selectivity and ultrasensitive detection of tau aggregate conformers of Alzheimer disease
por: Kraus, Allison, et al.
Publicado: (2018)

Protein-Capped Metal Nanoparticles Inhibit Tau Aggregation in Alzheimer’s Disease
por: Sonawane, Shweta Kishor, et al.
Publicado: (2019)

Espresso Coffee Mitigates the Aggregation and Condensation of Alzheimer′s Associated Tau Protein
por: Tira, Roberto, et al.
Publicado: (2023)

Novel model of secreted human tau protein reveals the impact of the abnormal N-glycosylation of tau on its aggregation propensity
por: Losev, Yelena, et al.
Publicado: (2019)

Tau Structures
por: Avila, Jesus, et al.
Publicado: (2016)

Metformin promotes tau aggregation and exacerbates abnormal behavior in a mouse model of tauopathy
por: Barini, Erica, et al.
Publicado: (2016)

Nasal Extracts from Patients with Alzheimer’s Disease Induce Tau Aggregates in a Cellular Model of Tau Propagation
por: Pahrudin Arrozi, Aslina, et al.
Publicado: (2021)

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease
por: Pichet Binette, Alexa, et al.
Publicado: (2022)

Propagation of Tau aggregates
por: Goedert, Michel, et al.
Publicado: (2017)

Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer’s disease
por: Balmik, Abhishek Ankur, et al.
Publicado: (2021)

Interleukin33 deficiency causes tau abnormality and neurodegeneration with Alzheimer-like symptoms in aged mice
por: Carlock, C, et al.
Publicado: (2017)

Interleukin33 deficiency causes tau abnormality and neurodegeneration with Alzheimer-like symptoms in aged mice
por: Carlock, C, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_89kfbd6b3o7koto9b380s49eic